Type 2 & other diabetes

AI framework for multidisease detection via retinal imaging

Nat MedPublished Diagnostic accuracy study

Study context

Population
Colour fundus photographs from community-based and hospital-based cohorts; six external cohorts from resource-limited and high-resource settings
Participants
107,730 colour fundus photographs
Comparison
Reti-Pioneer retinal imaging framework for multidisease detection
Outcome
AUC on internal test data
Methodological detailsmultitask deep learning framework, community-based and hospital-based cohorts, external validation in six cohorts, silent trial, clinical pilot
  • Multitask deep learning framework
  • Community-based and hospital-based cohorts
  • External validation in six cohorts
  • Silent trial
  • Clinical pilot

Performance

As reported in the abstract

AUC for T2D
0.833 (95% CI 0.810-0.856)
AUC for gout
0.832 (0.799-0.866)
AUC for osteoporosis
0.787 (0.742-0.833)
AUC for hypertension
0.740 (0.726-0.755)
AUC for hyperlipidemia
0.736 (0.721-0.751)
AUC for thyroid disease
0.699 (0.667-0.730)

Further findings

External validation

The framework generalized well to six external cohorts from both resource-limited and high-resource settings

Screening time per case in primary care silent trial

Screening time per case; notably faster than standard laboratory workflows
30.6 ± 6.0 s

Clinical pilot for T2D

AUC
0.776 (0.710-0.842)
NPV
0.966 (0.946-0.983)
Surpassed the Finnish Diabetes Risk Score

Original publication

AI framework for multidisease detection via retinal imaging. Nat Med. Published 28 April 2026. doi:10.1038/s41591-026-04359-w

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.